IM Cannabis Raises US$225,000 of Gross Proceeds in Convertible Note Financing
IM Cannabis Corp. (Nasdaq: IMCC) said it closed a US$225,000 convertible note private placement with an institutional investor. The note has 8% interest, rising to 14% on default, converts into common shares at the lower of US$0.152 or 90% of prior 20-day VWAP (floor US$0.0303), plus a 4.99% cap. It also issued warrants for up to 1,483,386 shares (C$0.22 exercise) and plans to use proceeds for general corporate purposes.
How this was made
The 30-second read
Why it matters
The financing provides $225,000 gross proceeds but is structured to convert into common shares, with an equity-linked conversion price formula and immediately exercisable warrants; the company also plans to file a Form F-3 resale registration statement to enable resale after hold periods.
Market read
Traders can model dilution and potential warrant-driven supply using the stated conversion price mechanics, discount, interest step-up on default, and the planned resale registration timeline.
What to watch
Conversion price uses a VWAP lookback with a floor, and the 4.99% beneficial ownership cap may limit immediate selling pressure from the lender; actual impact depends on current IMCC price vs. $0.152/$0.0303 and expected conversion timing.
Background
IM Cannabis (NASDAQ: IMCC) announced the closing of a private-placement convertible note financing with an institutional lender on July 1, 2026.
Ticker impact
IM Cannabis closed a $225,000 convertible note with 10% discount, 8% interest (14% on default), and conversion at the lower of $0.152 or 90% of prior VWAP.
Likely modest negative-to-neutral reaction as dilution/convertible overhang is priced, with sensitivity to the conversion price vs. current market.
The deal is newly closed and includes explicit conversion pricing, warrant issuance, and a resale-registration commitment—key inputs for dilution math—though the principal size is relatively small ($225k).
Market effects
Adds another small capital-raise example in medical cannabis, reinforcing ongoing funding needs and equity-linked financing structures.
Limited direct regional read-through beyond Israel/Germany cannabis operators’ financing cadence.
Low; this is a micro-cap sized financing with no stated cross-border strategic deal.
Counterpoint
The financing could be viewed as non-cash repayment (conversion-only) that reduces immediate liquidity stress, potentially supporting downside risk if cash burn is the main concern.
Key entities
- issuerIM Cannabis Corp.
Subject of the financing; issued the convertible note and warrants and intends to use proceeds for general corporate purposes.
- counterpartyLender (institutional investor)
Purchaser of the convertible note; receives conversion exposure and warrants subject to ownership limitations.
- securityJuly Note Warrants
Warrants for up to 1,483,386 common shares, exercisable immediately, expiring July 1, 2031.
